Who Owns RNAC?

Cartesian Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$6.89

-0.20 (-2.82%)

Market Cap

$234.6M

Shares Outstanding

26,509,000

Institutional Holders

73

Total Inst. Value

$84.8M

% of Float Held

QoQ Holder Change

+69

Institutional data as of Q1 2025

New Positions

15

Closed Positions

9

Increased

22

Decreased

19

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1FMR LLC$30.8M2,339,917
2MPM BioImpact LLC$10.4M790,779
3BlackRock, Inc.$8.9M673,050
4Siren, L.L.C.$7.4M563,272
5VANGUARD GROUP INC$6.6M503,537
6Erste Asset Management GmbH$3.5M2,787,011
7GEODE CAPITAL MANAGEMENT, LLC$3.0M225,500
8STATE STREET CORP$2.6M201,125
9JPMORGAN CHASE & CO$2.6M195,037
10683 Capital Management, LLC$2.0M150,000

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue
CITADEL ADVISORS LLC-168K$2K
FMR LLC-83K$30.8M
JPMORGAN CHASE & CO-80K$2.6M
Ikarian Capital, LLC-30K$292K
GOLDMAN SACHS GROUP INC-12K$208K

Related Stocks

Frequently Asked Questions

How many institutional investors hold RNAC?

As of Q1 2025, 73 institutional investors report holding RNAC (Cartesian Therapeutics, Inc.) in their 13F filings.

Which hedge fund owns the most RNAC?

The largest institutional holder of RNAC is FMR LLC with $30.8M in shares.

Are institutions buying or selling RNAC?

This quarter, 15 institutions opened new positions in RNAC and 9 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.